Development of Effective Vaccines against Multiple Lifecycle Stages of Plasmodium vivax malaria

Project Information

MultiViVax

Grant agreement ID: 733073

DOI 10.3030/733073

Project closed

EC signature date 9 December 2016

Start date 1 January 2017

End date 31 December 2022

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost € 5 736 576,25

EU contribution € 5 058 974,00

Coordinated by

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
United Kingdom

• Fresh search for a vaccine against malaria parasite Plasmodium vivax
  EN